| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Diagnostics LetPub Score 6.2
50 ratings
Rate
Reputation 7.2 Influence 5.2 Speed 7.3 | ||||||||||||||||||||
| 期刊簡稱 | DIAGNOSTICS | ||||||||||||||||||||
| ISSN | 2075-4418 | ||||||||||||||||||||
| h-index | N.A. | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 6.70%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | https://www.mdpi.com/journal/diagnostics | ||||||||||||||||||||
| 在線稿件提交 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | ||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||
| 出版商 | MDPI (Basel, Switzerland) | ||||||||||||||||||||
| 主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||
| 出版國/地區 | Poland | ||||||||||||||||||||
| 發行頻率 | |||||||||||||||||||||
| 創刊年 | 2011 | ||||||||||||||||||||
| 每年文章數 | 2849每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 99.96% | ||||||||||||||||||||
OA Related Info![]() | APC: Yes( CHF2600; ) APC waiver:Check Notes Other charges: No Keywords: medical diagnosis Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2075-4418%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 19.64 Day(s) 來自作者的數據: 11 Weeks | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Diagnostics] 的評論 | 撰寫評論 |
| 作者: 歹不歹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-25 10:47:47 評論於 Hello, I heard that units affiliated with hospitals will be rejected immediately, I would like to ask if this situation still exists in your journal. Thank you! |
| 作者: bzn 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2026-04-01 14:44:28 評論於 Is the unit a hospital? |
| 作者: clara 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2026-02-07 14:14:38 評論於 Submit for one month, return for revisions, and accepted for publication the day after revisions are made. |
| 作者: tinyone 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-10-06 00:14:24 評論於 1. After submitting the manuscript, feedback for revisions was given on the 20th day, with a 10-day window for revisions (the editor mentioned that they reached out to 3 reviewers but only received feedback from 2, in order to expedite the process, I was asked to respond to and make changes based on the feedback from these 2 reviewers). 2. Less than 12 hours after resubmitting the revised manuscript, feedback from the reviewers came back, with one reviewer suggesting further improvements (my heart skipped a beat at that moment), and the editor granted a 4-day window for revisions. 3. After the second round of revisions, a 6-day wait followed before the editor notified me of acceptance for publication (the elusive 3rd reviewer never made an appearance), with a request for proofreading using MDPI's service. This was completed in 5 hours, and the revised manuscript was resubmitted, with the galley proof received and approved the same evening. 4. Two days after the galley proof approval, the manuscript was published online. In summary: The process was relatively fast, with 20 days for review, 14 days for revisions, 6 days for the editor's decision on acceptance, for a total of 40 days. The online publication occurred on the 42nd day, overall providing a positive experience. |
| 作者: 贵在坚持 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-01 11:29:28 評論於 Excuse me, what is the current result? Any new progress? |
| 作者: 新蓝 領域: 计算机科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-25 23:28:21 評論於 I have been waiting for more than 20 days, and it is still under review. Is this normal? |
| 作者: 一定要中啊拜托 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-04-08 23:25:16 評論於 The publishing scale is relatively loose. The layout fee is 1800 Swiss francs. There may be a price increase in the second half of this year. |
| 作者: 一定要中啊拜托 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-04-08 23:24:18 評論於 pending review, approximately one week, very soon |
| 作者: wwwwac 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-30 20:41:54 評論於 How long does "pending review" usually take? |
| 作者: wwwwac 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-30 20:41:40 評論於 May I ask how long will it take for your pending review? |
| 作者: wwwwac 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-30 20:41:14 評論於 May I ask how long does pending review usually take? |
| 作者: 一定要中啊拜托 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-02-01 21:43:11 評論於 2022-12-22 Submission 2023-01-10 Major revision, 10-day deadline, 2 reviewers, differing opinions, the first reviewer had 4 "yes" and 2 "must", the second reviewer had 3 "can" and 3 "must", overall very comprehensive and detailed. 2023-01-18 Submitted after modifications. 2023-01-25 Accepted. 2023-01-31 Published online, searchable on SCI after approximately 1 month. |
| 作者: 英健 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-09-18 18:12:43 評論於 August 18, 2022, submission September 4, 2022, major revision, deadline 10 days, 3 reviewers September 13, 2022, submission after revision September 14, 2022, editorial decision September 18, 2022, accepted. |
| 作者: yigexue 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-01-06 10:18:08 評論於 How much is the layout fee? |
| 作者: EX-Engineer 領域: 医学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-07 16:00:12 評論於 Is it easy or not, I want to submit a paper to a relatively lenient journal. |
| 作者: gamesgenesis 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-07-28 15:57:40 評論於 6.10 submission 6.20 major revision, received comments from five reviewers 6.28 revision 7.8 minor revision, received comments from two reviewers 7.10 revision 7.28 acceptance Overall, it is a decent journal in MDPI, and the impact factor is expected to increase significantly in the future. |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us